Company: LHI
Filing Date: 2025-02-14
Form Type: DRS/A
Source: 0001213900-25-014190
Chunk: 58

Company: Living Homeopathy International Ltd.
Filing Date: 2025-02-14
Form: DRS/A
Chunk 58
---
 set up any
subsidiary or VIE structure in mainland China, (ii) our business operations remain to be primarily conducted in Hong Kong, and (iii)
we possess personal information of less than one million individuals in the PRC and we have never been recognized as a critical
information infrastructure operator in the PRC, subject to final determination by the CAC and relevant competent authorities, Han
Kun Law Offices, our PRC counsel, has advised that based upon the foregoing, we are not required to obtain any permission or
approval from the CAC or any other governmental authorities of mainland China to operate our business or to list Living
Homeopathy’s securities on the U.S. exchanges and offer securities.

Pursuant to the Basic Law, which is a national law of the PRC and the constitutional document for Hong Kong, national laws of the PRC shall not be applied in Hong Kong except for those listed in Annex III of the Basic Law and applied locally by promulgation or local legislation. The Basic Law expressly provides that the national laws of the PRC which may be listed in Annex III of the Basic Law shall be confined to those relating to defense and foreign affairs as well as other matters outside the autonomy of Hong Kong. The basic policies of the PRC regarding Hong Kong as a special administrative region of the PRC are reflected in the Basic Law, providing Hong Kong with a high degree of autonomy and executive, legislative and independent judicial powers, including that of final adjudication under the principle of “one country, two systems”.

<div align='center'>30</div>

However, as the government of mainland China
may choose to exercise significant oversight and discretion, and the policies, regulations, rules, and the enforcement of laws of the
government of mainland China to which we are subject may change rapidly and with little or no advance notice to us or our shareholders.
As a result, the application, interpretation, and enforcement of new and existing laws and regulations in mainland China are often uncertain.
In addition, these laws and regulations may be interpreted and applied inconsistently by different agencies or authorities, and may be
inconsistent with our current policies and practices. New laws, regulations, and other government directives in mainland China may also
be costly to comply with, and such compliance or any associated inquiries or investigations or any other government actions may:

| ● | delay                      
 or impede our development; |

| ● | result in negative publicity     
 or increase our operating costs; |

| ● | require significant management 
 time and